北大医药(000788.SZ)获批成为“磷酸奥司他韦干混悬剂”上市许可持有人

智通财经11-29

智通财经APP讯，北大医药(000788.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，涉及产品：“磷酸奥司他韦干混悬剂”。经审查，本品此次申请事项符合药品注册的有关要求，同意按照《药品上市后变更管理办法(试行)》相关规定，批准本品上市许可持有人由“山东朗诺制药有限公司” 变更为“北大医药股份有限公司”，药品批准文号不变。据悉，磷酸奥司他韦通过作用于流感病毒...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2487874385?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-29 16:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2487874385","market":"sh","top_or_hot":-1,"title":"北大医药(000788.SZ)获批成为“磷酸奥司他韦干混悬剂”上市许可持有人","media":"智通财经","content":"<div>\n<p>智通财经APP讯，北大医药(000788.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，涉及产品：“磷酸奥司他韦干混悬剂”。经审查，本品此次申请事项符合药品注册的有关要求，同意按照《药品上市后变更管理办法(试行)》相关规定，批准本品上市许可持有人由“山东朗诺制药有限公司” 变更为“北大医药股份有限公司”，药品批准文号不变。据悉，磷酸奥司他韦通过作用于流感病毒...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1217917.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>北大医药(000788.SZ)获批成为“磷酸奥司他韦干混悬剂”上市许可持有人</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n北大医药(000788.SZ)获批成为“磷酸奥司他韦干混悬剂”上市许可持有人\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-29 16:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1217917.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，北大医药(000788.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，涉及产品：“磷酸奥司他韦干混悬剂”。经审查，本品此次申请事项符合药品注册的有关要求，同意按照《药品上市后变更管理办法(试行)》相关规定，批准本品上市许可持有人由“山东朗诺制药有限公司” 变更为“北大医药股份有限公司”，药品批准文号不变。据悉，磷酸奥司他韦通过作用于流感病毒...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1217917.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1217917.html","article_id":"2487874385","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2487874385","pubTimestamp":1732869314,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，北大医药 发布公告，近日，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，涉及产品：“磷酸奥司他韦干混悬剂”。磷酸奥司他韦干混悬剂为2024年国家医保品种(乙类)，可用于成人以及2周龄以上儿童的甲型和乙型流感治疗，1周岁及以上儿童的流感预防，临床疗效显著，用药安全性好。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0028":"国家队","BK0096":"民营医院","000788":"北大医药","BK0060":"抗癌","BK0239":"医药制造","BK0012":"证金概念","BK0102":"重组","BK0122":"高校"},"translate_title":"Peking University Pharmaceutical (000788. SZ) was approved to become the marketing authorization holder of \"Oseltamivir Phosphate Dry Suspension\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000788":1},"content_text":"智通财经APP讯，北大医药(000788.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，涉及产品：“磷酸奥司他韦干混悬剂”。经审查，本品此次申请事项符合药品注册的有关要求，同意按照《药品上市后变更管理办法(试行)》相关规定，批准本品上市许可持有人由“山东朗诺制药有限公司” 变更为“北大医药股份有限公司”，药品批准文号不变。据悉，磷酸奥司他韦通过作用于流感病毒神经氨酸酶，抑制成熟的流感病毒脱离宿主细胞，以抑制流感病毒在体内的传播，起到预防和治疗流行性感冒的作用，被国内外多个诊疗指南推荐用于成人和儿童甲型和乙型流感的预防和治疗。磷酸奥司他韦干混悬剂为2024年国家医保品种(乙类)，可用于成人以及2周龄以上儿童的甲型和乙型流感治疗，1周岁及以上儿童的流感预防，临床疗效显著，用药安全性好。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2487874385"}